×

Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports

By Thomson Reuters Nov 19, 2026 | 9:18 AM

(Remove extraneous words at the end of story)

Nov 19 (Reuters) – ​Sanofi is weighing ‌an acquisition of US drugmaker Insmed, Bloomberg News reported on Thursday, ‌citing ​people familiar ⁠with the matter.

Shares ⁠of Insmed, which has a market valuation of $26.28 billion according ​to LSEG data, were up 16%. ⁠The companies ⁠did not immediately ​respond to Reuters’ requests ​for comment.

French drugmaker Sanofi ‌is speaking with advisers as it studies a potential deal ⁠for Insmed, Bloomberg reported, citing the people, who asked ⁠not ‌to be ⁠identified discussing confidential ​information.

Deliberations ‌are ongoing and ​any deal ⁠could still be weeks away, the report added.

(Reporting by Sneha S K; Editing by Maju ​Samuel)